87 related articles for article (PubMed ID: 21764682)
1. [Relationship between MAP3K5 and Epstein-Barr virus-encoded miR-BART22 expression in nasopharyngeal carcinoma].
Jiang QP; Liu SY; He XF; Peng J; Xiong HZ; Xiong ZT; Yang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1146-9. PubMed ID: 21764682
[TBL] [Abstract][Full Text] [Related]
2. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.
Lung RW; Tong JH; Sung YM; Leung PS; Ng DC; Chau SL; Chan AW; Ng EK; Lo KW; To KF
Neoplasia; 2009 Nov; 11(11):1174-84. PubMed ID: 19881953
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma.
Chen R; Zhang M; Li Q; Xiong H; Liu S; Fang W; Zhang Q; Liu Z; Xu X; Jiang Q
J Cancer; 2017; 8(2):305-313. PubMed ID: 28243335
[TBL] [Abstract][Full Text] [Related]
4. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
5. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.
Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W
EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma.
Chan JY; Gao W; Ho WK; Wei WI; Wong TS
Anticancer Res; 2012 Aug; 32(8):3201-10. PubMed ID: 22843893
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of EBV LMP2A in nasopharyngeal cancer specimens].
Xu J; Yao K; Yu C; Chen X; Li B; Sun H; Zhou F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun; 19(11):484-7. PubMed ID: 16124641
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
11. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
[TBL] [Abstract][Full Text] [Related]
12. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY
Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996
[TBL] [Abstract][Full Text] [Related]
13. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
Brousset P; Butet V; Chittal S; Selves J; Delsol G
Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
[TBL] [Abstract][Full Text] [Related]
16. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
You S; Yao K; Cao Y
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
Liu W; Han HX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):94-7. PubMed ID: 16495186
[TBL] [Abstract][Full Text] [Related]
19. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]